Manufacturer
Outlook Therapeutics
- Products listed
- 1
- Molecules
- 1
- Therapy areas
- 1
Outlook Therapeutics is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 1 of its products across 1 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Indian manufacturer
- No
- Also listed as
- Outlook Therapeutics, Inc.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Outlook Therapeutics products through licensed channels, with the documents your regulator needs.
Oncology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Lytenava 1.25 mg injectionIntravitreal Cold chain | Bevacizumab | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Outlook Therapeutics
Send a request for any of these products. We confirm the licensed source, documents and lead time.